Invesaro

Stocks Health care OABI

NASDAQ · Health care

OmniAb, Inc. (OABI)

OmniAb, Inc. brought in $38.5M of revenue over the twelve months to June 30, 2026, up 67.0% from a year earlier. It posted a net loss of $44.3M. In fiscal 2025 capital spending exceeded operating cash flow by $37M. At June 30, 2026 it held $24.3M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 6, 2026.

Price
$4.61
-3.76% on the day · September 25, 2026
52-week range $1.30 to $5.43
Market cap
$670.2M
Revenue (last 12 months)
$38.5M
+67.0% year on year
Net margin
-115.1%

What OmniAb, Inc. does

OmniAb, Inc. is registered with the SEC under industry code SIC 8731 (Services-Commercial Physical & Biological Research). Its shares trade on NASDAQ under the ticker OABI.

Revenue and profit by year

Revenue
FY21: $34.7M $34.7M FY21FY22: $59.1M $59.1M FY22FY23: $34.2M $34.2M FY23FY24: $26.4M $26.4M FY24FY25: $18.7M $18.7M FY25
Net income
FY21: -$27M -$27M FY21FY22: -$22.3M -$22.3M FY22FY23: -$50.6M -$50.6M FY23FY24: -$62M -$62M FY24FY25: -$64.8M -$64.8M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$18.7M-$69M-$64.8M-$0.57-$37M
2024$26.4M-$74.5M-$62M-$0.61-$41.5M
2023$34.2M-$69.4M-$50.6M-$0.51$703K
2022$59.1M-$26.6M-$22.3M-$0.26-$20.8M
2021$34.7M-$35.6M-$27M-$0.33-$9.7M

Latest SEC filings

What OmniAb, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 14, 2026
  2. August 6, 2026
    Quarterly report 10-Q · period to June 30, 2026
  3. August 6, 2026
  4. July 13, 2026
  5. June 18, 2026
  6. May 7, 2026
    Quarterly report 10-Q · period to March 31, 2026
  7. May 7, 2026
  8. April 29, 2026
  9. April 29, 2026
  10. April 29, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on August 3, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about OABI

What does OmniAb, Inc. do?

OmniAb, Inc. is registered with the SEC under industry code SIC 8731 (Services-Commercial Physical & Biological Research). Its shares trade on NASDAQ under the ticker OABI.

Is OmniAb, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $44.3M on revenue of $38.5M.

How much revenue does OmniAb, Inc. make?

Over the twelve months to June 30, 2026 OmniAb, Inc. reported revenue of $38.5M. That is 67.0% more than a year earlier.

When did OmniAb, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 6, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the passive stake changed from August 14, 2026.

Similar companies

Follow OABI

Get an email when OmniAb, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow OABI: get an email when it files

Where the numbers come from

Financial figures are the values OmniAb, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.